PT85572A - Polypeptide des rhinovirusstammes hrv89 sowie die hierfuer codierenden dna-molekuele - Google Patents
Polypeptide des rhinovirusstammes hrv89 sowie die hierfuer codierenden dna-molekueleInfo
- Publication number
- PT85572A PT85572A PT85572A PT8557287A PT85572A PT 85572 A PT85572 A PT 85572A PT 85572 A PT85572 A PT 85572A PT 8557287 A PT8557287 A PT 8557287A PT 85572 A PT85572 A PT 85572A
- Authority
- PT
- Portugal
- Prior art keywords
- herefuer
- hrv89
- polypeptides
- dna molecules
- coding dna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C07K16/106—
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32711—Rhinovirus
- C12N2770/32722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32711—Rhinovirus
- C12N2770/32734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863628658 DE3628658A1 (de) | 1986-08-23 | 1986-08-23 | Polypeptide des rhinovirusstammes hrv89 sowie die hierfuer codierenden dna-molekuele |
| DE19873701301 DE3701301A1 (de) | 1987-01-17 | 1987-01-17 | Herstellung von expressionsplasmiden fuer die viralen huellenproteinbereiche von hrv2 und hrv89 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT85572A true PT85572A (de) | 1987-09-01 |
| PT85572B PT85572B (pt) | 1990-05-31 |
Family
ID=25846814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT85572A PT85572B (pt) | 1986-08-23 | 1987-08-21 | Processo para a preparacao de polipeptidos da estirpe de rhinovirus hrv89 assim como de moleculas de dna que os codificam e de composicoes farmaceuticas que os contem |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0261403A3 (pt) |
| KR (1) | KR880003006A (pt) |
| AU (1) | AU617982B2 (pt) |
| DK (1) | DK438187A (pt) |
| FI (1) | FI873615L (pt) |
| IL (1) | IL83607A (pt) |
| NO (1) | NO873535L (pt) |
| NZ (1) | NZ221537A (pt) |
| PT (1) | PT85572B (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990001061A1 (de) * | 1988-07-25 | 1990-02-08 | Boehringer Ingelheim International Gmbh | In vitro synthese einer infektiösen rna |
| US6143298A (en) * | 1988-09-01 | 2000-11-07 | Bayer Corporation | Soluble truncated forms of ICAM-1 |
| US6514936B1 (en) | 1988-09-01 | 2003-02-04 | Bayer Corporation | Antiviral methods using human rhinovirus receptor (ICAM-1) |
| US6051231A (en) * | 1988-09-01 | 2000-04-18 | Bayer Corporation | Antiviral methods and prepations |
| DE68929096T2 (de) | 1988-09-01 | 2000-05-11 | Bayer Corp., Pittsburgh | Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt |
| ZA896668B (en) * | 1988-09-01 | 1990-06-27 | Molecular Therapeutics Inc | A human rhinovirus receptor protein that inhibits virus infectivity |
| US6107461A (en) * | 1990-07-20 | 2000-08-22 | Bayer Corporation | Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use |
| US5686581A (en) * | 1990-07-20 | 1997-11-11 | Bayer Corporation | Multimeric form of human rhinovirus receptor protein |
| US5686582A (en) * | 1990-07-20 | 1997-11-11 | Bayer Corporation | Multimeric forms of human rhinovirus receptor protein |
| ATE184049T1 (de) * | 1990-07-20 | 1999-09-15 | Bayer Ag | Multimere formen des menschlichen rhinovirus- rezeptorproteins |
| EP2316481A1 (en) * | 2009-10-30 | 2011-05-04 | Biomay Ag | Pharmaceutical composition for the treatment and prevention of a rhinovirus infection |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0169146A3 (en) * | 1984-07-20 | 1988-07-20 | Merck & Co. Inc. | Monoclonal antibodies directed against the cellular receptor of human rhinovirus |
| DE3505148A1 (de) * | 1985-02-15 | 1986-10-30 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Polypeptide des rhinovirusstammes hrv2 sowie die hierfuer codierenden dna-molekuele |
-
1987
- 1987-08-20 EP EP87112104A patent/EP0261403A3/de not_active Withdrawn
- 1987-08-21 DK DK438187A patent/DK438187A/da not_active Application Discontinuation
- 1987-08-21 AU AU77333/87A patent/AU617982B2/en not_active Ceased
- 1987-08-21 IL IL83607A patent/IL83607A/xx not_active IP Right Cessation
- 1987-08-21 FI FI873615A patent/FI873615L/fi not_active IP Right Cessation
- 1987-08-21 PT PT85572A patent/PT85572B/pt not_active IP Right Cessation
- 1987-08-21 NO NO873535A patent/NO873535L/no unknown
- 1987-08-21 NZ NZ221537A patent/NZ221537A/en unknown
- 1987-08-22 KR KR870009194A patent/KR880003006A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| IL83607A (en) | 1992-05-25 |
| FI873615A7 (fi) | 1987-12-18 |
| NO873535D0 (no) | 1987-08-21 |
| AU7733387A (en) | 1988-03-24 |
| AU617982B2 (en) | 1991-12-12 |
| EP0261403A2 (de) | 1988-03-30 |
| PT85572B (pt) | 1990-05-31 |
| KR880003006A (ko) | 1988-05-13 |
| DK438187D0 (da) | 1987-08-21 |
| NO873535L (no) | 1988-02-24 |
| NZ221537A (en) | 1991-07-26 |
| FI873615A0 (fi) | 1987-08-21 |
| DK438187A (da) | 1988-02-24 |
| IL83607A0 (en) | 1988-01-31 |
| FI873615L (fi) | 1988-02-24 |
| EP0261403A3 (de) | 1988-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK100985A (da) | Dna, der koder for human tumornecrosefaktor, samt humant tumornecrosefaktor-polypeptid og fremgangsmaader til fremstilling heraf | |
| DE3165463D1 (en) | Dna sequences, recombinant dna molecules and processes for producing human interferon-alpha like polypeptides | |
| DK3687D0 (da) | Polypeptider og fremgangsmaade til fremstilling deraf | |
| DK453288D0 (da) | Gasblander og -fordeler til reaktor | |
| NO168116C (no) | Hydrolyserbart harpikspreparat og dets anvendelse | |
| IT1203375B (it) | Catalizzatori complessi di stagno o bismuto e indurimento attinato di investimenti con essi | |
| DK122687A (da) | Polypeptid, dna og anvendelse deraf | |
| DE3752319D1 (de) | Prozess zur rekombinanten Herstellung von HIV-2 - Proteinen sowie Zellen, die HIV-2 - Proteine exprimiert | |
| NO850058L (no) | Modifisert kolofoniumharpiks, og fremgangsmaate til fremstilling og anvendelse derav | |
| ZA86217B (en) | Dna sequences,recombinant dna molecules and processes for producing human lipocortin-like polypeptides | |
| DE3688335D1 (de) | Ultraschallwandler und sein herstellungsverfahren. | |
| IT8823098A0 (it) | Procedimento per la sintesi di peptidi retro-inversi e nuovi intermedi in tale procedimento | |
| PT82026A (de) | Polupeptide des rhinovirusstammes hrv2 sowie die hierfuer codierenden dna-molekuele | |
| DK467487A (da) | Polypeptid, anvendeligt til lindring, behandling og diagnosticering af autoimmunitetssygdomme, isaer arthritis | |
| DE3774761D1 (de) | Dpcm-kodierer und zugehoeriger dekodierer. | |
| PT85572A (de) | Polypeptide des rhinovirusstammes hrv89 sowie die hierfuer codierenden dna-molekuele | |
| ZA876248B (en) | Polypeptides of the rhinovirus strain hrv89 and the dna molecules coding therefor | |
| NO872323D0 (no) | Harpiksprodukt og fremgangsmaate for dets fremstilling. | |
| DK64387A (da) | Beskyttende overtraeksmateriale og dets anvendelse | |
| FI863626A7 (fi) | DNA-sekvenssejä, yhdistelmä-DNA -molekyylejä ja menetelmiä ihmisen lip okortiinin kaltaisia polypeptidejä. | |
| DE3585890D1 (de) | Peptid und dafuer kodierendes gen. | |
| DK203087D0 (da) | Proteiner og fremgangsmaade til fremstilling deraf | |
| IE860414L (en) | "polypeptides of the rhinovirus strain hrv2 and the dna¹molecules coding therefor" | |
| DE58901122D1 (de) | Verwendung von tnf und lt zur herstellung von arzneimitteln. | |
| DK266187A (da) | Rekombinant humant protein s, fremgangsmaade til fremstilling heraf og rekombinant dna-vektor til brug ved fremgangsmaaden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 19940531 |